Investors must take note of Takeda Pharmaceutical Co ADR’s (TAK) performance last week, which was -2.82%.
Takeda Pharmaceutical Co ADR (NYSE: TAK) kicked off on Monday, down -1.80% from the previous trading day, before settling in for the closing price of